HALOZYME THERAPEUT earnings per share and revenue

RV7 earnings per share for the last quarter are 0.71 CHF whereas the estimation was 0.62 CHF which accounts for 15.07% surprise. Company revenue for the same period amounts to 176.71 M CHF despite the estimated figure of 180.19 M CHF. Estimated earnings per share for the next quarter are 0.65 CHF, and revenue is expected to reach 181.78 M CHF. Also watch annual changes over time to get a bigger picture of RV7 earnings per share and revenue dynamics.